Stock Analysis on Net
Stock Analysis on Net

Allergan PLC (NYSE:AGN)

This company has been moved to the archive! The financial data has not been updated since May 7, 2020.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Allergan PLC, common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Accounts payable and accrued expenses 5.98 6.70 6.03 5.23 4.73 4.70 4.41 4.30 4.53 4.68 3.82 3.76 3.78 3.89 3.78 3.39 3.45 3.20 3.16 4.30 4.17
Income taxes payable 0.08 0.07 0.09 0.10 0.13 0.07 0.17 0.09 0.10 0.06 0.19 0.13 0.06 0.04 0.55 0.07 0.05 0.04 0.06 0.05 0.07
Current portion of long-term debt 2.21 4.79 3.96 3.24 4.05 0.85 1.27 1.24 0.56 3.58 3.19 3.04 4.36 2.17 1.11 1.89 2.95 1.79 1.43 1.12 1.16
Current portion of lease liability, operating 0.14 0.13 0.13 0.13 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.02
Current liabilities held for sale 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.16 1.34 1.04 1.10 1.01 0.00 0.01
Deferred tax liabilities 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.04 0.05
Current liabilities 8.41% 11.69% 10.21% 8.70% 9.03% 5.63% 5.85% 5.63% 5.19% 8.32% 7.19% 6.93% 8.19% 6.11% 5.59% 6.69% 7.49% 6.13% 5.69% 5.53% 5.49%
Long-term debt, excluding current portion 19.90 19.13 19.90 20.54 19.95 22.53 20.87 22.05 23.15 21.84 22.30 21.20 20.67 23.24 21.71 27.96 28.33 29.66 28.46 29.85 30.62
Lease liability, operating, excluding current portion 0.50 0.47 0.46 0.43 0.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other long-term liabilities 0.89 0.85 0.86 0.86 0.82 0.87 0.71 0.69 0.74 0.75 0.85 0.83 0.84 0.84 0.71 0.78 0.75 0.93 0.81 0.88 0.91
Long-term liabilities held for sale 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.36 0.38 0.43 0.45 0.00 0.00
Other taxes payable 1.91 1.80 1.82 1.75 1.65 1.59 1.48 1.45 1.39 1.33 0.77 0.72 0.72 0.69 0.57 0.56 0.57 0.59 0.53 0.66 0.71
Deferred tax liabilities 2.78 4.61 4.79 5.20 5.34 5.41 4.90 4.72 4.95 5.37 9.08 10.01 10.29 10.05 8.92 5.86 5.56 5.88 9.80 11.01 11.07
Long-term liabilities 25.98% 26.86% 27.83% 28.78% 28.18% 30.39% 27.96% 28.91% 30.23% 29.29% 32.99% 32.76% 32.52% 34.82% 31.93% 35.52% 35.59% 37.49% 40.05% 42.40% 43.31%
Total liabilities 34.38% 38.55% 38.04% 37.48% 37.21% 36.01% 33.81% 34.54% 35.42% 37.61% 40.19% 39.69% 40.71% 40.92% 37.52% 42.21% 43.08% 43.62% 45.75% 47.93% 48.80%
Preferred shares, $0.0001 par value per share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.17 4.14 3.95 3.89 3.82 3.43 3.72 3.62 3.63 3.45 3.56 3.53
Ordinary shares; $0.0001 par value per share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Treasury shares, at cost 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.28 0.00 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 63.37 59.11 59.19 58.45 56.86 55.52 53.69 52.88 51.32 45.64 45.70 43.51 42.66 41.83 46.09 51.85 50.46 50.43 47.78 49.20 48.74
Retained earnings (accumulated deficit) 1.00 1.05 1.64 2.70 4.67 7.13 11.08 11.10 11.43 10.95 8.52 11.54 12.17 14.22 12.82 2.46 2.82 2.69 3.04 -0.69 -0.51
Accumulated other comprehensive income (loss) 1.22 1.27 1.10 1.34 1.24 1.32 1.41 1.46 1.82 1.62 1.44 1.30 0.57 -0.81 0.42 -0.24 0.02 -0.36 -0.03 -0.01 -0.56
Shareholders’ equity 65.59% 61.43% 61.94% 62.50% 62.77% 63.97% 66.18% 65.45% 64.57% 62.38% 59.80% 60.30% 59.28% 59.07% 62.48% 57.79% 56.92% 56.38% 54.25% 52.07% 51.20%
Noncontrolling interest 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total equity 65.62% 61.45% 61.96% 62.52% 62.79% 63.99% 66.19% 65.46% 64.58% 62.39% 59.81% 60.31% 59.29% 59.08% 62.48% 57.79% 56.92% 56.38% 54.25% 52.07% 51.20%
Total liabilities and equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Allergan PLC current liabilities as a percentage of total liabilities and equity increased from Q3 2019 to Q4 2019 but then decreased significantly from Q4 2019 to Q1 2020.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Allergan PLC long-term liabilities as a percentage of total liabilities and equity decreased from Q3 2019 to Q4 2019 and from Q4 2019 to Q1 2020.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Allergan PLC total liabilities as a percentage of total liabilities and equity increased from Q3 2019 to Q4 2019 but then decreased significantly from Q4 2019 to Q1 2020.
Shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Allergan PLC shareholders’ equity as a percentage of total liabilities and equity decreased from Q3 2019 to Q4 2019 but then increased from Q4 2019 to Q1 2020 exceeding Q3 2019 level.